Arcellx (ACLX) Current Leases (2022 - 2025)

Arcellx's quarterly Current Leases came in at $7.4 million in Q1 2025, down 77.37% year-on-year from $32.5 million in Q1 2024, and up 3100.43% quarter-over-quarter from $230000.0 in Q4 2024.

Arcellx has reported Current Leases for 4 years, with the latest figure at $7.4 million in Q1 2025.

  • For the quarter ending Q1 2025, Current Leases fell 77.37% year-over-year to $7.4 million; the trailing twelve-month figure through Mar 2025 stood at $7.4 million (down 77.37% YoY), and the FY2024 full-year result was $230000.0, down 96.93% from the prior year.
  • Current Leases for Q1 2025 stood at $7.4 million, up from $230000.0 in the prior quarter.
  • The five-year high for Current Leases was $38.0 million in Q2 2023, with the low at $230000.0 in Q4 2024.
  • Average Current Leases over 4 years is $14.4 million, with a median of $7.4 million recorded in 2025.
  • Year-over-year, Current Leases surged 4942.0% in 2023 and sank 96.93% in 2024.
  • Tracing ACLX's Current Leases over 4 years: stood at $2.9 million in 2022, then surged by 158.57% to $7.5 million in 2023, then slumped by 96.93% to $230000.0 in 2024, then surged by 3100.43% to $7.4 million in 2025.
  • The last three Current Leases figures came in at $7.4 million (Q1 2025), $230000.0 (Q4 2024), and $7.3 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 Arcellx 6.48 Bn 6.48 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 7.36 Mn
Dec 31, 2024 230,000.00
Sep 30, 2024 7.25 Mn
Jun 30, 2024 19.22 Mn
Mar 31, 2024 32.53 Mn
Dec 31, 2023 7.50 Mn
Sep 30, 2023 6.58 Mn
Jun 30, 2023 38.05 Mn
Mar 31, 2023 35.29 Mn
Dec 31, 2022 2.90 Mn
Sep 30, 2022 27.73 Mn
Jun 30, 2022 2.31 Mn
Mar 31, 2022 700,000.00